Issue 115 • February 2022 Anaesthesia drugs worst-hit by US drug shortages A cloudy day in paradise for pharma tax havens Aduhelm qualms continue with Medicare verdict In association with Mapping the RNA therapeutics R&D landscape in 2022 Fueled by the successful utilisation of the mRNA Covid-19 vaccines, RNA therapeutics are expected to make larger strides in 2022 In association with 02/24/2024 14:17:37